Diamyd Medical ABDiamyd Medical AB - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

This assessment of Diamyd Medical AB is assembled by All Street Sevva using leading AI. Jump to the bottom of this page for potential risks for Diamyd Medical AB based on industry, location and marketcap. The page is a zero-cost Sustainability report covering Diamyd Medical AB.

Diamyd Medical AB in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.5; made up of an environmental score of 4.0, social score of 6.7 and governance score of 5.7.

SDG Transparency Score for Diamyd Medical AB 
Low
0 - 3

5.5

Medium Impact
4 - 6
High
7 - 10
Last Score Update: 2023-07-01
What drives the score for Diamyd Medical AB 
4.0

Environmental

6.7

Social

5.7

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Novartis AG
9.2
High
2Daiichi Sankyo Co Ltd
8.9
High
808Tilray Inc
5.6
High
808Y-mAbs Therapeutics Inc
5.6
High
835Diamyd Medical AB
5.5
High
835Animalcare Group PLC
5.5
High
835Bafna Pharmaceuticals Ltd
5.5
High
.........
2749Xynomic Pharmaceuticals Holdings Inc
0.0
Low
2749Zyden Gentec Ltd
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Diamyd Medical AB have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Diamyd Medical AB disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Diamyd Medical AB report the average age of the workforce?

LockedSign up for free to unlock

Does Diamyd Medical AB reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Diamyd Medical AB disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Diamyd Medical AB disclose cybersecurity risks?

LockedSign up for free to unlock

Does Diamyd Medical AB offer flexible work?

LockedSign up for free to unlock

Does Diamyd Medical AB have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Diamyd Medical AB disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Diamyd Medical AB conduct supply chain audits?

LockedSign up for free to unlock

Does Diamyd Medical AB disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Diamyd Medical AB conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Diamyd Medical AB disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Diamyd Medical AB disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Diamyd Medical AB disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Diamyd Medical AB disclose water use targets?

LockedSign up for free to unlock

Does Diamyd Medical AB have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Diamyd Medical AB have a product recall in the last two years?

LockedSign up for free to unlock

Does Diamyd Medical AB disclose incidents of discrimination?

LockedSign up for free to unlock

Does Diamyd Medical AB allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Diamyd Medical AB issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Diamyd Medical AB disclose parental leave metrics?

LockedSign up for free to unlock

Does Diamyd Medical AB disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Diamyd Medical AB disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Diamyd Medical AB disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Diamyd Medical AB support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Diamyd Medical AB disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Diamyd Medical AB reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Diamyd Medical AB involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Diamyd Medical AB disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Diamyd Medical AB disclose its waste policy?

LockedSign up for free to unlock

Does Diamyd Medical AB report according to TCFD requirements?

LockedSign up for free to unlock

Does Diamyd Medical AB disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Diamyd Medical AB disclose energy use targets?

LockedSign up for free to unlock

Does Diamyd Medical AB disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Diamyd Medical AB have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Diamyd Medical AB
These potential risks are based on the size, segment and geographies of the company.

Diamyd Medical AB (publ) develops therapies for the treatment of autoimmune diabetes. The company develops Diamyd, an antigen-specific immunotherapy diabetes vaccine, which is in phase III clinical trial for the treatment of type 1 diabetes and latent autoimmune diabetes; and Remygen, an oral regenerative and immunomodulatory drug candidate, which is in phase I/II clinical trial for the treatment of autoimmune and type 2 diabetes. The company was formerly known as Diamyd Therapeutics AB and changed its name to Diamyd Medical AB (publ) in April 2013. Diamyd Medical AB (publ) was incorporated in 1984 and is based in Stockholm, Sweden.

Sorry!

Failed to process!